Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
InVivo Therapeutics Holdings Corp. (NVIVQ) had Operating Cash Flow per Share of $-6.82 for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
-- |
|
$-10.49M |
|
-- |
|
-- |
|
$10.65M |
|
$-10.65M |
|
$0.16M |
|
$-10.49M |
|
$-10.49M |
|
$-10.49M |
|
$-10.49M |
|
$-10.49M |
|
$-10.49M |
|
$-10.65M |
|
$-10.59M |
|
1.54M |
|
1.54M |
|
$-6.83 |
|
$-6.83 |
|
| Balance Sheet Financials | |
$17.60M |
|
$0.23M |
|
$1.22M |
|
$18.82M |
|
$2.47M |
|
-- |
|
$0.61M |
|
$3.08M |
|
$15.75M |
|
$15.75M |
|
$15.75M |
|
2.43M |
|
| Cash Flow Statement Financials | |
$-10.48M |
|
$-0.16M |
|
$7.96M |
|
$19.18M |
|
$16.50M |
|
$-2.68M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-66.62% |
|
-66.62% |
|
-55.73% |
|
-66.62% |
|
$6.48 |
|
$-6.93 |
|
|
Operating Cash Flow per Share |
$-6.82 |